Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Powell Michael
Relationship:   10% Owner
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   21    
Direct Shares   22,645,475    

Indirect Shares

   6,181,468      
Direct Value   $15,525,538    

Indirect Value

   $148,318,095      
Total Shares   28,826,943      
Total Value   $163,843,634      


Seagen Inc $4,575,029 Molecular Templates, Inc. $2,064,809 Anesiva Inc $0 Paratek Pharmaceuticals Inc $96,365 Humanigen Inc $124 Aravive Inc $86,094 Aclaris Therapeutics, Inc. $2,403,954 Entasis Therapeutics Holdings Inc. $2,584,590 Nextcure, Inc. $0 Iterum Therapeutics Plc $1,618,998 Akouos, Inc. $0 Inozyme Pharma, Inc. $0 Bolt Biotherapeutics, Inc. $2,095,576 Vera Therapeutics, Inc. $0 Seagen Inc $4,575,029 Molecular Templates, Inc. $2,064,809 Anesiva Inc $0 Paratek Pharmaceuticals Inc $96,365 Humanigen Inc $124 Aravive Inc $86,094 Aclaris Therapeutics, Inc. $2,403,954 Entasis Therapeutics Holdings Inc. $2,584,590 Nextcure, Inc. $0 Iterum Therapeutics Plc $1,618,998 Akouos, Inc. $0 Inozyme Pharma, Inc. $0 Bolt Biotherapeutics, Inc. $2,095,576 Vera Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    2    

     Stock price went up :
    0   
    2    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   2.0   
     Percentage Gain/Loss :
   -63.7%
 32.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Seagen Inc SGEN Director 2004-12-16 20,001 2004-12-16 647,577    Premium*  
            Molecular Templates, Inc. MTEM Director 2005-03-08 3,440,201 2006-03-16 12,846    Premium*  
            Anesiva Inc ANSVQ Director, 10% Owner 2007-12-18 65 2007-12-18 4,906,973    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-09 43,213 0    Premium*  
            Orexigen Therapeutics, Inc. OREX Director 2010-12-23 1 2010-12-23 0    Premium*  
            Trius Therapeutics Inc TSRX Director 2010-08-06 0 2012-03-26 9,302    Premium*  
            Humanigen Inc HGEN 10% Owner 2013-02-05 414,394 2013-02-05 0    Premium*  
            Ocera Therapeutics Inc OCRX Director 2016-07-29 0 2016-10-31 14,328    Premium*  
            Aravive Inc ARAV 10% Owner 2014-03-26 2,146,978 2014-03-26 0    Premium*  
            Hyperion Therapeutics Inc HPTX 10% Owner 2015-05-07 0 2014-06-04 0    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2014-07-10 0 2014-07-09 0    Premium*  
            Marinus Pharmaceuticals Inc MRNS 10% Owner 2014-08-05 0 2016-10-20 15,470    Premium*  
            Synlogic Inc SYBX Director 2015-10-05 0 2018-01-26 574,972    Premium*  
            Aclaris Therapeutics, Inc. ACRS 10% Owner 2015-10-13 2,289,480 2015-10-13 0    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2018-09-28 1,180,178 2018-09-28 0    Premium*  
            Nextcure, Inc. NXTC 10% Owner 2019-11-15 2,671,856 2019-11-15 0    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2020-06-02 1,226,514 2020-06-01 0    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 1,515,073 2020-06-30 0    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 2,028,308 2020-07-28 0    Premium*  
            Bolt Biotherapeutics, Inc. BOLT 10% Owner 2021-02-09 2,754,437 2021-02-09 0    Premium*  
            Vera Therapeutics, Inc. VERA 10% Owner 2021-05-18 2,914,776 2021-05-18 0    Premium*  
* Premium Members only  

Records found :    126         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •      –    2004-11-15 4 S $6.70 $609,619 I/I (89,500) 939,766 -
SGEN Seagen Inc Director   –       •      –    2004-11-16 4 S $6.90 $372,845 I/I (54,000) 887,251 -
SGEN Seagen Inc Director   –       •      –    2004-11-29 4 S $7.00 $49,160 I/I (7,000) 880,443 -
SGEN Seagen Inc Director   –       •      –    2004-12-01 4 S $6.90 $176,300 I/I (25,500) 855,644 -
SGEN Seagen Inc Director   –       •      –    2004-12-02 4 S $6.91 $414,999 I/I (59,300) 797,975 -
SGEN Seagen Inc Director   –       •      –    2004-12-03 4 S $7.00 $482,525 I/I (68,200) 731,650 -
SGEN Seagen Inc Director   –       •      –    2004-12-06 4 S $7.25 $55,800 I/I (7,500) 724,356 -
SGEN Seagen Inc Director   –       •      –    2004-12-07 4 S $7.00 $157,904 I/I (22,450) 702,523 -
SGEN Seagen Inc Director   –       •      –    2004-12-14 4 S $7.00 $280,000 I/I (40,000) 663,623 -
SGEN Seagen Inc Director   –       •      –    2004-12-15 4 S $7.00 $70,000 I/I (10,000) 653,898 -
SGEN Seagen Inc Director   –       •      –    2004-12-16 4 S $7.00 $45,500 I/I (6,500) 647,577 -
SYBX Synlogic Inc Director   –       •       •   2015-10-05 4 A $0.00 $0 I/I 1,827,828 1,827,828 0 -
SYBX Synlogic Inc Director   –       •       •   2015-10-06 4 B $7.00 $5,999,994 I/I 857,142 2,974,811 2.25 -
SYBX Synlogic Inc Director   –       •       •   2015-10-06 4 A $0.00 $0 I/I 289,841 2,117,669 0 -
SYBX Synlogic Inc Director   –       •      –    2018-01-26 4 A $9.75 $1,462,500 I/I 150,000 574,972 0 -
TSRX Trius Therapeutics Inc Director   –       •       •   2010-08-06 4 A $0.00 $3,913,070 I/I 2,785,572 2,785,572 0 -
TSRX Trius Therapeutics Inc Director   –       •       •   2010-08-06 4 B $5.00 $4,150,000 I/I 830,000 3,615,572 2.25 -
TSRX Trius Therapeutics Inc Director   –       •       •   2012-01-12 4 A $0.00 $0 I/I 144,622 144,622 0 -
TSRX Trius Therapeutics Inc Director   –       •       •   2012-01-12 4 AS $0.00 $0 I/I (3,615,572) 28 0 -
TSRX Trius Therapeutics Inc Director   –       •      –    2012-01-13 4 AS $5.46 $46,568 I/I (8,522) 136,100 0 -
TSRX Trius Therapeutics Inc Director   –       •      –    2012-01-17 4 AS $5.43 $87,426 I/I (16,100) 120,000 0 -
TSRX Trius Therapeutics Inc Director   –       •      –    2012-01-18 4 AS $5.56 $23,895 I/I (4,300) 115,700 0 -
TSRX Trius Therapeutics Inc Director   –       •      –    2012-01-19 4 AS $5.64 $14,662 I/I (2,600) 113,100 0 -
TSRX Trius Therapeutics Inc Director   –       •      –    2012-03-26 4 OE $1.29 $12,000 I/I 9,302 9,302 0 -
VERA Vera Therapeutics, Inc. 10% Owner   –       –       •   2021-05-18 4 B $11.00 $7,999,992 D/D 727,272 2,914,776 2.45 -
  126  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us